Category: SARS-CoV-2

Inexpensive Antidepressant Found to Reduce COVID-19 Hospitalizations by Over 30 Percent: Study

An inexpensive antidepressant drug has been found to reduce the risk of hospitalization in high-risk adults recently diagnosed with COVID-19 by over 30 percent, according to a study published in The Lancet Global Health. The study, titled, “Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised,…


CDC Issued Last-Minute Changes to School Reopening Guidance After Being Asked by Teachers Unions, Emails Show

The Centers for Disease Control and Prevention (CDC) issued last-minute changes to its school-reopening guidance after two prominent teachers unions asked the agency to do so, according to newly obtained emails by watchdog group Americans for Public Trust. The emails, obtained through a Freedom of Information Act request by the watchdog and published online show a string of communications between…


EpochTV Review: Things That Make You Go Hmm…

Commentary Once upon a time, not that long ago, we had something called reporters in the United States. Millennials and Gen-Z’ers may not believe this, but there were actually people employed by newspapers and television stations who would gather the news and then report on it without any overt political spin or coordinated narrative. Reporters…


WHO Urges China to Share Raw Data on Early COVID-19 Cases, Says It’s ‘Vitally Important’ to Prevent Future Pandemics

The World Health Organisation (WHO) on Aug. 12 urged China to share raw data from the earliest COVID-19 cases, saying it is “vitally important to know how the COVID-19 pandemic began” and to set an example for establishing the origins of all future animal-human spillover events. In a statement on Thursday, the WHO repeatedly stressed the importance of…


More Adverse Reactions Reported After COVID-19 Vaccination in People With Prior Infection: Study

Healthcare workers who have recovered from COVID-19, except those with Long-COVID, reported adverse reactions following their first dose of the Pfizer/BioNTech vaccine more often than those who had not been infected, according to a recent study. Researchers in the United Kingdom surveyed more than 900 healthcare workers in three hospitals in a longitudinal observational study,…